Kevin Boehnke

K. F. Boehnke is a clinical researcher whose work focuses on naturalistic and survey-based investigations of psychedelic use and its effects in community and patient populations. Their recent projects include studies of user attitudes toward the cost of psychedelic treatments and interest in non-hallucinogenic alternatives; retrospective surveys of major life changes following psychedelic use; analyses of changed substance use after psychedelic experiences in Canada; investigations into utilisation and trust of psychedelic information sources among naturalistic users; and examination of knowledge, perceptions and use of psychedelics among people with fibromyalgia.

Across these studies, Boehnke has contributed to the evidence base on real-world psychedelic practices, harm-reduction-relevant behavioural outcomes, and the informational ecology that shapes user decision-making. Their work is characterised by quantitative survey methods applied to diverse populations (including chronic pain cohorts), with an emphasis on patient-centred outcomes, public attitudes to emerging therapeutic options, and the implications of non-hallucinogenic treatment alternatives for access and acceptability.